Abstract: A method of treating a mammal with one of a central nervous system injury and a neurodegenerative disorder comprising isolating, culturing, and generating neural progenitor cells from a mammalian placenta, and transplanting the placenta derived neural progenitor cells into a brain of the mammal.

Abstract: This present disclosure relates to a method for preparation of polyvinylidene fluoride membrane with functional anthraquinones. The method is carried out according, to the following steps: step 1: preparing 2-(1-hydroxy-3-butene)-1,4,5,8-tetramethoxyl naphthalene; step 2: preparing polyvinylidene fluoride-aromatic ether copolymers: polyvinylidene fluoride was used as the initiator, 2-(1-hydroxy-3-butene) -1,4,5,8-tetramethoxynaphthalene was the monomer, N,N-dimethylformamide was solvent, cuprous chloride/Me6TREN was the catalytic, polyvinylidene fluoride-aromatic ether copolymer was synthesized by atomic transfer radical polymerization; step 3: reducing the polyvinylidene fluoride-aromatic ether copolymer to quinone by demethoxy oxidation; step 4: using the product of step 3 and N, N-dimethylformamide a film-forming reagents, then scraping into a membrane. Further, the anthraquinone which fixed in the polyvinylidene fluoride membrane would not fall off.

Abstract: A method enabling symmetric routing between a first host within a first AS and a second host within a second AS is disclosed. The method includes detecting that a first routing message was received at an edge router of the first AS from an edge router of the second AS. The first message identifies the second host as a source and the first host as a destination of a forward route. The method further includes determining that the first message further comprises an indication to implement symmetric routing between the first and second hosts and generating a second routing message for propagating to router(s) within the first AS. The second message identifies the first host as a source and the second host as a destination of a return route, and indicates that data is to be sent via the edge router of the first AS that received the first message.

Abstract: Disclosed herein are nanoactuating rotaxanes comprising a threading component, the threading component comprising a oligoviologen, and at least two macrocylic components, wherein the oligoviologen is threaded through each of the macrocylic components. Also disclosed are methods for making and using the rotaxanes.

Abstract: The present invention relates to a passive low temperature heat energy organic working fluid power generation method and system, Comprising: organic working fluid in a first evaporator and a second evaporator are heated to evaporate; when a pressure of the organic working fluid reaches a setting pressure, a self-operating pressure control valve at an outlet of the evaporator is triggered opening by a working pressure, and steam of the organic working fluid flows into a turbine, pushes the turbine to work, and drives a generator to output electric energy; after work is completed, the steam flows into a condenser to be condensed, and working steam is output in turn through the first evaporator and the second evaporator, and thus the turbine is driven continuously to work and output electric energy. Compared with the prior technology, the present invention has reliable performance, and is operated by heating and evaporating of the working fluid in a closed space to achieve increased pressure.

Abstract: A method of generating one of podocyte progenitor cells and neural stem/progenitor cells comprising the steps of collecting a urine specimen from a patient; centrifuging the urine specimen; and removing the one of podocyte progenitor cells and neural stem/progenitor cells.

Abstract: The present application provides a method and a system for detecting data of an instrument.

Abstract: A method for workflow management in a medical workflow management system wherein a first user logs in to the workflow management system running a desktop application and next identifies an additional, non logged-in user and defines at least one task of the workflow for this additional user. Selection of an additional user and defined task(s) triggers the workflow management system to associate the defined task(s) of the workflow with the additional user.

Abstract: A method enabling symmetric routing between a first host within a first AS and a second host within a second AS is disclosed. The method includes detecting that a first routing message was received at an edge router of the first AS from an edge router of the second AS. The first message identifies the second host as a source and the first host as a destination of a forward route. The method further includes determining that the first message further comprises an indication to implement symmetric routing between the first and second hosts and generating a second routing message for propagating to router(s) within the first AS. The second message identifies the first host as a source and the second host as a destination of a return route, and indicates that data is to be sent via the edge router of the first AS that received the first message.

Abstract: A method for neighbor discovery including: transmitting a neighbor detection message according to a neighbor VLAN information table, where the neighbor VLAN information table includes neighbor VLAN information; receiving a neighbor response message with which a terminal responds; acquiring a MAC address of the terminal according to the neighbor response message. With the method, numerous invalid detections, heavy apparatus load and large CPU resource consumption caused by traversing a public network VLAN and a private network VLAN to conduct neighbor detection decease.

Abstract: A telescopic light source electrosurgical pencil comprises a handle with a control circuit internally configured. One end of the handle is connected to a cutter head. Two sides of a joint by which the handle is connected to the cutter head are both provided with an LED lamp I and an LED lamp II parallelly arranged on the handle. The handle is provided with an electric cutting switch and an electric coagulation switch, the other end of the handle being provided with an LED lamp switch for controlling the LED lamps. The handle is further connected to a cable, the cable being connected to a plug connected to an electric cutter machine and a power adapter connector. This telescopic light source electrosurgical pencil employs a structure of parallelly arranged LED lamps for illumination, which effectively improves the luminance of the surgical view and thus brings great convenience to surgeries.

Abstract: The present invention relates to a passive type low-temperature heat sources organic working fluid power generation method. The organic working fluid absorbs heat and evaporates in the first evaporator and the second in turn evaporator. When the pressure of organic working fluid reaches the set pressure, the self-operated pressure regulator valve at the outlet of the evaporator opens triggered by operating pressure. The organic working fluid vapor flows into the turbine and pushes the turbine to rotate with a high speed, driving the generator to provide output power. The low-temperature low-pressure exhaust gas flows into the condenser and condenses into liquid working fluid. Through the first and second evaporator in turn providing working steam, the turbine can maintain continuous work and provide output power. Compared with the prior technology, the present invention has reliable performance, relying on the evaporation of the working fluid in a closed space to achieve increased pressure.

Abstract: A composition is provided for modulating or attenuating the cytokine induced cell surface expression of cell adhesion molecules, comprising an antibody that binds digoxin. There is also provided a method of modulating or attenuating the cytokine induced cell surface expression of a cell adhesion molecule in a patient by administering to a digoxin antibody composition to a patient in need of such treatment.

Abstract: The invention relates to N-heterocyclic substituent-containing antibiotics, their preparation, and their use. Disclosed are sodium and potassium salts of 7-(?-((N,N?-diisopropylamidino)thio)acetylamino)-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-diox o-1,2,4-triazin-3-yl)thio)methyl) cephalosporanic acid as presented by the general structure (I), their preparation, and their use. The antibiotics of the invention can be used to treat diseases caused by Gram-positive or Gram-negative bacteria such as septicaemia, gastrointestinal tract infection, and urinary tract infection. They have increased half-life in blood and lowered toxicity. They can reduce the frequency of drug use and lower medical treatment costs. They have improved stability and can be stored at ambient temperatures. The method of the invention is simple, and it produces high purity products which can meet the requirements of clinical use.

Abstract: A method for neighbor discovery including: transmitting a neighbor detection message according to a neighbor VLAN information table, where the neighbor VLAN information table includes neighbor VLAN information; receiving a neighbor response message with which a terminal responds; acquiring a MAC address of the terminal according to the neighbor response message. With the method, numerous invalid detections, heavy apparatus load and large CPU resource consumption caused by traversing a public network VLAN and a private network VLAN to conduct neighbor detection decease.

Abstract: A composition is provided for modulating or attenuating the cytokine induced cell surface expression of cell adhesion molecules, comprising an antibody that binds digoxin. There is also provided a method of modulating or attenuating the cytokine induced cell surface expression of a cell adhesion molecule in a patient by administering to a digoxin antibody composition to a patient in need of such treatment.

Abstract: Anti-infection levorotatory optically active compound (S-configuration) of prulifloxacin represented by the following formula (1) and preparation method thereof are disclosed. Said method utilizes levorotatory ulifloxacin as the raw material and the reaction is conducted in organic solvent in the presence of alkaline materials, wherein the reaction temperature is ?20° C.˜60° C. and the reaction time is 15 minutes to 24 hours.

Abstract: The present invention relates to a N-substituted matrinic acid derivative or matrine derivative, and its preparation method and uses. Specifically, the present invention relates to a compound of Formula (I) or (II) (wherein all the definitions of substituted groups are those mentioned in the specification), or a pharmaceutically acceptable salt, geometric isomer, stereoisomer, solvate, ester or prodrug thereof. The present invention further relates to a method for preparing the compound of the present invention, a pharmaceutical composition containing the compound, and uses thereof in manufacture of a medicament. The compound of the present invention can be used for prophylaxis and/or treatment of a disease or disorder associated with viral infection such as hepatitis B and/orhepatitis C and/or AIDS.

Abstract: Anti-infection levorotatory optically active compound (S-configuration) of prulifloxacin represented by the following formula (1) and preparation method thereof are disclosed. Said method utilizes levorotatory ulifloxacin as the raw material and the reaction is conducted in organic solvent in the presence of alkaline materials, wherein the reaction temperature is ?20° C.˜60° C. and the reaction time is 15 minutes to 24 hours.

Abstract: The invention relates to N-heterocyclic substituent-containing antibiotics, their preparation, and their use. Disclosed are sodium and potassium salts of 7-(?-((N,N?-diisopropylamidino)thio)acetylamino)-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl) cephalosporanic acid as presented by the general structure (I), their preparation, and their use. The antibiotics of the invention can be used to treat diseases caused by Gram-positive or Gram-negative bacteria such as septicaemia, gastrointestinal tract infection, and urinary tract infection. They have increased half-life in blood and lowered toxicity. They can reduce the frequency of drug use and lower medical treatment costs. They have improved stability and can be stored at ambient temperatures. The method of the invention is simple, and it produces high purity products which can meet the requirements of clinical use.